Ichioka D, Kawai K, Tanaka K, Ishitsuka R, Yoshino T, Kimura T, Kandori S,Kawahara T, Kojima T, Usui J, Yamagata K, Miyazaki J, Nishiyama H. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicularcancer survivors treated with cisplatin-based chemotherapy. Clin Exp Nephrol.2017 Sep 25. doi: 10.1007/s10157-017-1474-x. [Epub ahead of print] PubMed PMID:28948387.
Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urol. 2017 May 21. doi: 10.1111/iju.13376. [Epub ahead of print] Review. PubMed PMID: 28543959.
Inokuchi J, Eto M, Hara T, Fujimoto H, Nishiyama H, Miyazaki J, Kikuchi E, Hinotsu S, Koie T, Ohyama C; Cancer Registration Committee of the Japanese Urological Association.. Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association. Jpn J Clin Oncol. 2017 Apr 7:1-8. doi: 10.1093/jjco/hyx051. [Epub ahead of print] PubMed PMID: 28398494.
Kojima T, Kawai K, Miyazaki J, Nishiyama H. Biomarkers for precision medicine in bladder cancer. Int J Clin Oncol. 2016 Nov 29. [Epub ahead of print] Review.PubMed PMID: 27896485.
Ishitsuka R, Miyazaki J, Ichioka D, Inoue T, Kageyama S, Sugimoto M, Mitsuzuka K, Matsui Y, Shiraishi Y, Kinoshita H, Wakeda H, Nomoto T, Kikuchi E, Kawai K, Nishiyama H. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients. Clin Exp Nephrol. 2017 Aug;21(4):732-740. doi:10.1007/s10157-016-1327-z.
Takaoka EI,, Miyazaki J, Ishikawa H, Kawai K, Kimura T, Ishitsuka R, Kojima T, Kanuma R, Takizawa D, Okumura T, Sakurai H, Nishiyama H. Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer. Jpn J Clin Oncol. 2017 Jan;47(1):67-73.
Sekido N, Yoshino T, Takaoka E,, Waku N, Tanaka K, Nishiyama H, Ochi H, Satoh T. Impact of adjuvant radiotherapy and reversibility of neurogenic bladder on bladder storage function and impact of urethral resistance on bladder emptying function after radical hysterectomy. Open J Urol. 7(12): 252-265, 2017.
Akaza H, Onozawa M, Hinotsu S. Prostate cancer trends in Asia. World J Urol. 2017 Jun;35(6):859-865.
Onozawa M, Akaza H. Recent Trends in Hormone Therapy for Prostate Cancer in Japan. In Arai Y, Ogawa O (eds.). Hormone Therapy and Castration Resistance of Prostate Cancer. Springer Nature Singapore Pre Ltd. 2018.
